About Pattern Bioscience
Pattern Bioscience is a private company based in Austin, Texas. It has reported $83,691,345 raised in five offerings on Form D since April 2018. Its chief executive is Carey-Ann Burnham.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 31, 2025 | Aug 18, 2025 | $44,221,343of $61.2M target | 6 | $7.3M | EquityRule 506(b) | Form D ↗ |
| Dec 28, 2022 | Jan 12, 2023 | $23,499,993of $31.9M target | 4 | $5.8M | EquityRule 506(b) | Form D ↗ |
| Jun 29, 2020 | Jul 10, 2020 | $6,000,001of $9.0M target | 1 | $6.0M | EquityRule 506(b) | Form D ↗ |
| Aug 30, 2019 | Sep 11, 2019amended Oct 23, 2019 | $6,420,008of $6.9M target | 13 | $493K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Mar 20, 2018 | Apr 3, 2018 | $3,550,000of $4.0M target | 10 | $355K | EquityRule 506(b) | Form D ↗ |
| Total, five offerings | $83,691,345 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Pattern Bioscience's Form D filed Aug 18, 2025.
JG
Junjun Gao
Director
SM
Scott Mendel
Director
GW
Greg Wood
Director
NN
Nicholas Naclerio
Director
PB
Patrick Balthrop
Director
NA
Nicolas Arab
Executive officer and director
CB
Carey-Ann Burnham
Chief Executive Officer and director
Earlier filings also listed Bryan Gammon (director, last listed Jan 2023), Ross Johnson (executive officer and promoter, last listed Oct 2019) and Oscar Marx III (director, last listed Oct 2019).